Creative BioTherapeutics
Illinois-based Creative BioTherapeutics develops innovative therapies for cancer and viruses, revolutionizing disease research.
Founded
2016Illinois-based Creative BioTherapeutics develops innovative therapies for cancer and viruses, revolutionizing disease research.
Founded in Gurnee, Illinois, Creative BioTherapeutics is a biotechnology company dedicated to developing innovative therapies for cancer and viral diseases. The company's core mission is to revolutionize disease research by addressing the root causes of immune evasion and drug resistance in cancer. Creative BioTherapeutics offers breakthrough biologics, such as their lead product CBT300, which aims to increase overall survival rates without typical toxicity. Their market focus is on late-stage diseases that are often considered untreatable.
Creative BioTherapeutics has garnered attention for its pioneering approach to tackling some of the most challenging types of cancer. The company has attracted notable investors and industry experts who support its mission to bring hope to patients facing dire prognoses. Among its key achievements is the development of CBT300, which has shown promising results in preclinical studies. Overall, Creative BioTherapeutics is making a significant impact in the biotech industry by offering new avenues for treatment and hope for patients with late-stage diseases.
Companies similar to Creative BioTherapeutics include Therabiol, Duet BioTherapeutics, ImmunoGenesis and Fuse Biotherapeutics.
Creative BioTherapeutics was founded in 2016.
Creative BioTherapeutics' headquarters is located in Gurnee, IL, US.
Creative BioTherapeutics' most recent funding round was for $80k (USD) in February 2023.
As of Feb 8, 2023, Creative BioTherapeutics has disclosed funding of $1.4M (USD). Undisclosed round amounts are excluded.
Creative BioTherapeutics has 6 employees as of Feb 5, 2024.
Fuse Biotherapeutics
fusebiotx.com
